A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles
- 1 April 2004
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 69 (4) , 271-278
- https://doi.org/10.1016/j.contraception.2003.11.003
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenoneThe European Journal of Contraception & Reproductive Health Care, 2000
- Influence of two low-dose oral contraceptives containing ethinylestradiol (20 µg) and desogestrel or gestodene on carbohydrate metabolism during 1 year of useGynecological Endocrinology, 1996
- Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolismJournal of Clinical Endocrinology & Metabolism, 1995
- Low‐dose combined oral contraceptivesBJOG: An International Journal of Obstetrics and Gynaecology, 1994
- Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women.BMJ, 1993
- Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.Journal of Clinical Investigation, 1993
- Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controlsJournal of Clinical Endocrinology & Metabolism, 1993
- Oral contraceptives and lipids.BMJ, 1989
- The triglyceride issue: A view from FraminghamAmerican Heart Journal, 1986
- Epidemiology as a Guide to Clinical DecisionsNew England Journal of Medicine, 1980